Skip to main content
Erschienen in: Journal of Neurology 1/2007

01.01.2007 | ORIGINAL COMMUNICATION

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease

verfasst von: Nicolaas I. Bohnen, MD, PhD, Satyanarayana Gedela, MD, MRCP, Hiroto Kuwabara, MD, PhD, Gregory M. Constantine, PhD, Chester A. Mathis, PhD, Stephanie A. Studenski, MD, MPH, Robert Y. Moore, MD, PhD

Erschienen in: Journal of Neurology | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Olfactory dysfunction is a frequent and early feature of Parkinson’s disease (PD), often preceding the motor symptoms by several years. Assessment of olfactory deficits may be used in the diagnostic assessment of PD. In this study we investigated the relationship between selective deficits in smell identification and nigrostriatal dopaminergic denervation in patients with PD. Twenty-seven PD patients (Hoehn and Yahr stages I-III) and 27 healthy controls matched for gender and age underwent olfactory testing using the 40-odor University of Pennsylvania Smell Identification Test (UPSIT). PD patients underwent 11C-β-CFT dopamine transporter (DAT) positron emission tomography (PET) imaging and clinical motor examination. We found that total UPSIT scores were significantly lower in the PD than in the control subjects (z = 4.7, p < 0.0001). Analysis of the individual smell scores identified 3 odors with an accuracy of >0.75 for the diagnosis of PD. These odors were banana, licorice, and dill pickle. A PD-specific smell identification score (UPSIT-3) was calculated for these 3 odors. Analysis of the patient PET data demonstrated significant correlations between dorsal striatal DAT activity and the UPSIT-3 (RS = 0.53, p = 0.0027) and total UPSIT (RS = 0.44, p = 0.023) scores. UPSIT-3 (RS = 0.43, p = 0.027) but not total UPSIT (RS = 0.20, ns) correlated with nigral DAT activity. We conclude that patients with PD have selective hyposmia. A simplified UPSIT smell identification test consisting of 3 PD-selective odors had more robust correlation with nigral and dorsal striatial dopaminergic activity compared with the full UPSIT scores in patients with PD. Assessment of selective olfactory deficits may be used as a simplified olfactory screening test in the evaluation of subjects with possible PD.
Literatur
1.
Zurück zum Zitat Berendse HW, Booij J, Francot CM, Bergmans PL, Hijman R, Stoof JC, Wolters EC (2001) Subclinical dopaminergic dysfunction in asymptomatic Parkinson’s disease patients’ relatives with a decreased sense of smell. Ann Neurol 50: 34–41PubMedCrossRef Berendse HW, Booij J, Francot CM, Bergmans PL, Hijman R, Stoof JC, Wolters EC (2001) Subclinical dopaminergic dysfunction in asymptomatic Parkinson’s disease patients’ relatives with a decreased sense of smell. Ann Neurol 50: 34–41PubMedCrossRef
2.
Zurück zum Zitat Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20: 415–455PubMedCrossRef Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20: 415–455PubMedCrossRef
3.
Zurück zum Zitat Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24: 197–211PubMedCrossRef Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24: 197–211PubMedCrossRef
4.
Zurück zum Zitat Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318: 121–134PubMedCrossRef Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318: 121–134PubMedCrossRef
5.
Zurück zum Zitat Brooks D (1998) The early diagnosis of Parkinson’s disease. Ann Neurol 44(Suppl. 1): S10–S18PubMed Brooks D (1998) The early diagnosis of Parkinson’s disease. Ann Neurol 44(Suppl. 1): S10–S18PubMed
6.
Zurück zum Zitat Chaudhuri KR, Yates L, Martinez-Martin P (2005) The non-motor symptom complex of Parkinson’s disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 5: 275–283PubMed Chaudhuri KR, Yates L, Martinez-Martin P (2005) The non-motor symptom complex of Parkinson’s disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 5: 275–283PubMed
7.
Zurück zum Zitat Daum RF, Sekinger B, Kobal G, Lang CJG (2000) Riechprüfung mit “sniffin’ sticks” zur klinischen Diagnostic des Morbus Parkinson. Nervenarzt 71: 643–650PubMedCrossRef Daum RF, Sekinger B, Kobal G, Lang CJG (2000) Riechprüfung mit “sniffin’ sticks” zur klinischen Diagnostic des Morbus Parkinson. Nervenarzt 71: 643–650PubMedCrossRef
8.
Zurück zum Zitat Davila NG, Blakemore LJ, Trombley PQ (2003) Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture. J Neurophysiol 90: 395–404PubMedCrossRef Davila NG, Blakemore LJ, Trombley PQ (2003) Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture. J Neurophysiol 90: 395–404PubMedCrossRef
9.
Zurück zum Zitat Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38: 1237–1244PubMed Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38: 1237–1244PubMed
10.
Zurück zum Zitat Doty RL, Shaman P, Dann M (1984) Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 32: 489–502PubMedCrossRef Doty RL, Shaman P, Dann M (1984) Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 32: 489–502PubMedCrossRef
11.
Zurück zum Zitat Doty RL, Shaman P, Kimmelman CP, Dann MS (1984) University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 94: 176–178PubMedCrossRef Doty RL, Shaman P, Kimmelman CP, Dann MS (1984) University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 94: 176–178PubMedCrossRef
12.
Zurück zum Zitat Doty RL, Singh A, Tetrud J, Langston JW (1992) Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol 32: 97–100PubMedCrossRef Doty RL, Singh A, Tetrud J, Langston JW (1992) Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol 32: 97–100PubMedCrossRef
13.
Zurück zum Zitat Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 55: 138–142PubMed Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 55: 138–142PubMed
14.
Zurück zum Zitat Double KL, Rowe DB, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Halliday GM (2003) Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol 60: 545–549PubMedCrossRef Double KL, Rowe DB, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Halliday GM (2003) Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol 60: 545–549PubMedCrossRef
15.
Zurück zum Zitat Fahn S, Elton R (1987) Members of the UPDRS development committee. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan Healthcare Information, Florham Park, NJ, pp 153–164 Fahn S, Elton R (1987) Members of the UPDRS development committee. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan Healthcare Information, Florham Park, NJ, pp 153–164
16.
Zurück zum Zitat Farley IJ, Price KS, Hornykiewicz O (1977) Dopamine in the limbic regions of the human brain: normal and abnormal. Adv Biochem Psychopharmacol 16: 57–64PubMed Farley IJ, Price KS, Hornykiewicz O (1977) Dopamine in the limbic regions of the human brain: normal and abnormal. Adv Biochem Psychopharmacol 16: 57–64PubMed
17.
Zurück zum Zitat Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56: 33–39PubMedCrossRef Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56: 33–39PubMedCrossRef
18.
Zurück zum Zitat Hack MA, Saghatelyan A, de Chevigny A, Pfeifer A, Ashery-Padan R, Lledo PM, Gotz M (2005) Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci 8: 865–867PubMed Hack MA, Saghatelyan A, de Chevigny A, Pfeifer A, Ashery-Padan R, Lledo PM, Gotz M (2005) Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci 8: 865–867PubMed
19.
Zurück zum Zitat Hawkes CH, Shephard BC (1993) Selective anosmia in Parkinson’s disease? Lancet 341: 435–436PubMedCrossRef Hawkes CH, Shephard BC (1993) Selective anosmia in Parkinson’s disease? Lancet 341: 435–436PubMedCrossRef
20.
Zurück zum Zitat Henderson JM, Lu Y, Wang S, Cartwright H, Halliday GM (2003) Olfactory deficits and sleep disturbances in Parkinson’s disease: a case-control survey. J Neurol Neurosurg Psychiatry 74: 956–958PubMedCrossRef Henderson JM, Lu Y, Wang S, Cartwright H, Halliday GM (2003) Olfactory deficits and sleep disturbances in Parkinson’s disease: a case-control survey. J Neurol Neurosurg Psychiatry 74: 956–958PubMedCrossRef
21.
Zurück zum Zitat Hoehn M, Yahr M (1967) Parkinsonism: onset, progression, and mortality. Neurology 17: 427–442PubMedCrossRef Hoehn M, Yahr M (1967) Parkinsonism: onset, progression, and mortality. Neurology 17: 427–442PubMedCrossRef
22.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181–184PubMed Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181–184PubMed
23.
Zurück zum Zitat Huisman E, Uylings HB, Hoogland PV (2004) A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease. Mov Disord 19: 687–692PubMedCrossRef Huisman E, Uylings HB, Hoogland PV (2004) A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease. Mov Disord 19: 687–692PubMedCrossRef
24.
Zurück zum Zitat Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H, Suhara T, Suzuki K, Innis RB, Carson RE (2003) Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23: 1096–1112PubMedCrossRef Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H, Suhara T, Suzuki K, Innis RB, Carson RE (2003) Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23: 1096–1112PubMedCrossRef
25.
Zurück zum Zitat Katzenschlager R, Lees AJ (2004) Olfaction and Parkinson’s syndromes: its role in differential diagnosis. Curr Opin Neurol 17: 417–423PubMedCrossRef Katzenschlager R, Lees AJ (2004) Olfaction and Parkinson’s syndromes: its role in differential diagnosis. Curr Opin Neurol 17: 417–423PubMedCrossRef
26.
Zurück zum Zitat Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. N Eng J Med 318: 876–880CrossRef Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. N Eng J Med 318: 876–880CrossRef
27.
Zurück zum Zitat Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE (1991) Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11: 735–744PubMed Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE (1991) Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11: 735–744PubMed
28.
Zurück zum Zitat Korten JJ, Meulstee J (1980) Olfactory disturbances in parkinsonism. Clin Neurol Neurosurg 82: 113–118PubMedCrossRef Korten JJ, Meulstee J (1980) Olfactory disturbances in parkinsonism. Clin Neurol Neurosurg 82: 113–118PubMedCrossRef
29.
Zurück zum Zitat Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4: 153–158PubMedCrossRef Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4: 153–158PubMedCrossRef
30.
Zurück zum Zitat Lehrner J, Brucke T, Kryspin-Exner I, Asenbaum S, Podreka I (1995) Impaired olfactory function in Parkinson’s disease. Lancet 345: 1054–1055PubMedCrossRef Lehrner J, Brucke T, Kryspin-Exner I, Asenbaum S, Podreka I (1995) Impaired olfactory function in Parkinson’s disease. Lancet 345: 1054–1055PubMedCrossRef
31.
Zurück zum Zitat Mackinnon A (2000) A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Comput Biol Med 30: 127–134PubMedCrossRef Mackinnon A (2000) A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Comput Biol Med 30: 127–134PubMedCrossRef
32.
Zurück zum Zitat McLean JH, Shipley MT (1988) Postmitotic, postmigrational expression of tyrosine hydroxylase in olfactory bulb dopaminergic neurons. J Neurosci 8: 3658–3669PubMed McLean JH, Shipley MT (1988) Postmitotic, postmigrational expression of tyrosine hydroxylase in olfactory bulb dopaminergic neurons. J Neurosci 8: 3658–3669PubMed
33.
Zurück zum Zitat Montgomery EBJ, Koller WC, LaMantia TJ, Newman MC, Swanson-Hyland E, Kaszniak AW, Lyons K (2000) Early detection of probable idiopathic Parkinson’s disease: I. Development of a diagnostic test battery. Mov Disord 15: 467–473PubMedCrossRef Montgomery EBJ, Koller WC, LaMantia TJ, Newman MC, Swanson-Hyland E, Kaszniak AW, Lyons K (2000) Early detection of probable idiopathic Parkinson’s disease: I. Development of a diagnostic test battery. Mov Disord 15: 467–473PubMedCrossRef
34.
Zurück zum Zitat Montgomery EBJ, Lyons K, Koller WC (2000) Early detection of probable idiopathic Parkinson’s disease: II. A prospective application of a diagnostic test battery. Mov Disord 15: 474–478PubMedCrossRef Montgomery EBJ, Lyons K, Koller WC (2000) Early detection of probable idiopathic Parkinson’s disease: II. A prospective application of a diagnostic test battery. Mov Disord 15: 474–478PubMedCrossRef
35.
Zurück zum Zitat Moore RY, Whone AL, McGowan S, Brooks DJ (2003) Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study. Brain Res 982: 137–145PubMedCrossRef Moore RY, Whone AL, McGowan S, Brooks DJ (2003) Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study. Brain Res 982: 137–145PubMedCrossRef
36.
Zurück zum Zitat Nagren K, Halldin C, Muller L, Swahn CG, Lehikoinen P (1995) Comparison of [11C]methyl triflate and [11C]methyl iodide in the synthesis of PET radioligands such as [11C]beta-CIT and [11C]beta-CFT. Nucl Med Biol 22: 965–979PubMedCrossRef Nagren K, Halldin C, Muller L, Swahn CG, Lehikoinen P (1995) Comparison of [11C]methyl triflate and [11C]methyl iodide in the synthesis of PET radioligands such as [11C]beta-CIT and [11C]beta-CFT. Nucl Med Biol 22: 965–979PubMedCrossRef
37.
Zurück zum Zitat Nagren K, Muller L, Halldin C, Swahn CG, Lehikoinen P (1995) Improved synthesis of some commonly used PET radioligands by the use of [11C]methyl triflate. Nucl Med Biol 22: 235–239PubMedCrossRef Nagren K, Muller L, Halldin C, Swahn CG, Lehikoinen P (1995) Improved synthesis of some commonly used PET radioligands by the use of [11C]methyl triflate. Nucl Med Biol 22: 235–239PubMedCrossRef
38.
Zurück zum Zitat Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters EC, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol 56: 173–181PubMedCrossRef Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters EC, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol 56: 173–181PubMedCrossRef
39.
Zurück zum Zitat Siderowf A, Newberg A, Chou KL, Lloyd M, Colcher A, Hurtig HI, Stern MB, Doty RL, Mozley PD, Wintering N, Duda JE, Weintraub D, Moberg PJ (2005) [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology 64: 1716–1720PubMedCrossRef Siderowf A, Newberg A, Chou KL, Lloyd M, Colcher A, Hurtig HI, Stern MB, Doty RL, Mozley PD, Wintering N, Duda JE, Weintraub D, Moberg PJ (2005) [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology 64: 1716–1720PubMedCrossRef
40.
Zurück zum Zitat Stern MB (2004) The preclinical detection of Parkinson’s disease: ready for prime time? Ann Neurol 56: 169–171PubMedCrossRef Stern MB (2004) The preclinical detection of Parkinson’s disease: ready for prime time? Ann Neurol 56: 169–171PubMedCrossRef
41.
Zurück zum Zitat Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, Wolters EC (2001) Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Dis 16: 41–46CrossRef Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, Wolters EC (2001) Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Dis 16: 41–46CrossRef
42.
Zurück zum Zitat Wang J, Eslinger PJ, Smith MB, Yang QX (2005) Functional magnetic resonance imaging study of human olfaction and normal aging. J Gerontol A Biol Sci Med Sci 60: 510–514PubMed Wang J, Eslinger PJ, Smith MB, Yang QX (2005) Functional magnetic resonance imaging study of human olfaction and normal aging. J Gerontol A Biol Sci Med Sci 60: 510–514PubMed
43.
Zurück zum Zitat Weinhard K (1998) Applications of 3D PET. In: Bendriem B, Townsend DW (eds) The theory and practice of 3D PET. Kluwer Academic Publishers, Boston, pp 133–167 Weinhard K (1998) Applications of 3D PET. In: Bendriem B, Townsend DW (eds) The theory and practice of 3D PET. Kluwer Academic Publishers, Boston, pp 133–167
44.
Zurück zum Zitat Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, Kuhn G, Winkler J (2006) Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 197: 113–121PubMedCrossRef Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, Kuhn G, Winkler J (2006) Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 197: 113–121PubMedCrossRef
45.
Zurück zum Zitat Wiseman MB, Nichols TE, Woods RP, Sweeney JA, Mintun MA (1995) Stereotaxic techniques comparing foci intensity and location of activation areas in the brain as obtained using positron emission tomography (PET). J Nucl Med 36(suppl): 93p Wiseman MB, Nichols TE, Woods RP, Sweeney JA, Mintun MA (1995) Stereotaxic techniques comparing foci intensity and location of activation areas in the brain as obtained using positron emission tomography (PET). J Nucl Med 36(suppl): 93p
46.
Zurück zum Zitat Wolters EC, Francot C, Bergmans P, Winogrodzka A, Booij J, Berendse HW, Stoof JC (2000) Preclinical (premotor) Parkinson’s disease. J Neurol 247(Suppl2:II): 103–109 Wolters EC, Francot C, Bergmans P, Winogrodzka A, Booij J, Berendse HW, Stoof JC (2000) Preclinical (premotor) Parkinson’s disease. J Neurol 247(Suppl2:II): 103–109
47.
Zurück zum Zitat Woods RP, Mazziota JC, Cherry SR (1993) MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17: 536–546PubMedCrossRef Woods RP, Mazziota JC, Cherry SR (1993) MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17: 536–546PubMedCrossRef
48.
Zurück zum Zitat Wu Y, Carson RE (2002) Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab 22: 1440–1452PubMedCrossRef Wu Y, Carson RE (2002) Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab 22: 1440–1452PubMedCrossRef
Metadaten
Titel
Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease
verfasst von
Nicolaas I. Bohnen, MD, PhD
Satyanarayana Gedela, MD, MRCP
Hiroto Kuwabara, MD, PhD
Gregory M. Constantine, PhD
Chester A. Mathis, PhD
Stephanie A. Studenski, MD, MPH
Robert Y. Moore, MD, PhD
Publikationsdatum
01.01.2007
Erschienen in
Journal of Neurology / Ausgabe 1/2007
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-006-0284-y

Weitere Artikel der Ausgabe 1/2007

Journal of Neurology 1/2007 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.